Roivant Sciences (ROIV) Other Non Operating Income (2020 - 2025)
Roivant Sciences (ROIV) posted Other Non Operating Income of -$8.6 million for Q4 2025, down 50.33% on a QoQ basis from -$5.7 million in Q3 2025, and down 8.67% year-over-year from -$9.4 million in Q4 2024.
Roivant Sciences (ROIV) Other Non Operating Income (2020 - 2025) Analysis & Trends
Roivant Sciences' Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$8.6 million for Q4 2025.
- Quarterly Other Non Operating Income fell 8.67% year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$33.3 million (down 854.96% YoY) and the FY2026 annual result came in at $4.0 million, up 29.09% from the prior year.
- Other Non Operating Income was -$8.6 million for Q4 2025 at Roivant Sciences, down from -$5.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $18.1 million in Q4 2022 and bottomed at -$11.2 million in Q2 2025.
- A 5-year average of $577076.9 and a median of -$1.5 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 909.7% — and 2023, when it soared 523.32%.
- Roivant Sciences' Other Non Operating Income stood at $134000.0 in 2021, then surged by 13403.73% to $18.1 million in 2022, then dropped by 4.1% to $17.4 million in 2023, then tumbled by 145.39% to -$7.9 million in 2024, then declined by 8.67% to -$8.6 million in 2025.
- Business Quant data shows ROIV's Other Non Operating Income at -$8.6 million in Q4 2025, -$5.7 million in Q3 2025, and -$11.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.56 Mn |
| Sep 30, 2025 | -5.69 Mn |
| Jun 30, 2025 | -11.21 Mn |
| Dec 31, 2024 | -7.88 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Dec 31, 2023 | 17.35 Mn |
| Sep 30, 2023 | 12.76 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Sep 30, 2022 | -5.95 Mn |
| Jun 30, 2022 | -1.09 Mn |
| Jun 30, 2021 | 134,000.00 |
| Dec 31, 2020 | 5.79 Mn |
| Sep 30, 2020 | 757,000.00 |
| Jun 30, 2020 | -2.84 Mn |